Steven P. Gelone - Sep 30, 2021 Form 4 Insider Report for Nabriva Therapeutics plc (NBRVF)

Role
President and COO, Director
Signature
/s/ J. Christopher Naftzger, by power of attorney
Stock symbol
NBRVF
Transactions as of
Sep 30, 2021
Transactions value $
-$75
Form type
4
Date filed
10/4/2021, 04:09 PM
Previous filing
Sep 8, 2021
Next filing
Oct 8, 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NBRVF Ordinary Shares Tax liability -$75 -63 -0.02% $1.19 367K Sep 30, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These ordinary shares were withheld by the Issuer in order to satisfy tax withholding obligations upon the vesting of certain restricted share units.

Remarks:

Exhibit Index: 24.1 - Power of Attorney